Brief: Exagen, Others Collaborate To Develop Novel Patented Biomarkers Into Clinical Diagnostic Tests
04/05/2021 21:35
May 4 (Reuters) - Exagen Inc XGN.O :
* EXAGEN INC., ALLEGHENY HEALTH NETWORK RESEARCH INSTITUTE
AND AHN
AUTOIMMUNITY INSTITUTE ANNOUNCE COLLABORATION TO DEVELOP NOVEL
PATENTED BIOMARKERS INTO CLINICAL DIAGNOSTIC TESTS
Source text for Eikon: ID:nGNX6bcncC
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance